Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial

C. Dickhoff; S. Senan; F. L. Schneiders; J. Veltman; S. Hashemi; M. Fransen; D. Heineman; T. Radonic; P. van de Ven; L. Meijboom; D. Oprea-Lager; J. Garcia-Vallejo; N. Bouwhuis; T. D. de Gruijl; I. Bahce

doi:https://doi.org/10.1016/j.annonc.2021.10.137

Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial

C. Dickhoff, S. Senan, F. L. Schneiders, J. Veltman, S. Hashemi, M. Fransen, D. Heineman, T. Radonic, P. van de Ven, L. Meijboom, D. Oprea-Lager, J. Garcia-Vallejo, N. Bouwhuis, T. D. de Gruijl, I. Bahce

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S1427-S1427
Journal	Annals of Oncology
Volume	32
DOIs	https://doi.org/10.1016/j.annonc.2021.10.137
Publication status	Published - Dec 2021

Access to Document

https://doi.org/10.1016/j.annonc.2021.10.137

Cite this

Dickhoff, C., Senan, S., Schneiders, F. L., Veltman, J., Hashemi, S., Fransen, M., Heineman, D., Radonic, T., van de Ven, P., Meijboom, L., Oprea-Lager, D., Garcia-Vallejo, J., Bouwhuis, N., de Gruijl, T. D., & Bahce, I. (2021). Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial. Annals of Oncology, 32, S1427-S1427. https://doi.org/10.1016/j.annonc.2021.10.137

@article{d6014ff41bd14034b8c24698c62ee3b8,

title = "Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial",

author = "C. Dickhoff and S. Senan and Schneiders, {F. L.} and J. Veltman and S. Hashemi and M. Fransen and D. Heineman and T. Radonic and {van de Ven}, P. and L. Meijboom and D. Oprea-Lager and J. Garcia-Vallejo and N. Bouwhuis and {de Gruijl}, {T. D.} and I. Bahce",

year = "2021",

month = dec,

doi = "https://doi.org/10.1016/j.annonc.2021.10.137",

language = "English",

volume = "32",

pages = "S1427--S1427",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Dickhoff, C , Senan, S , Schneiders, FL , Veltman, J , Hashemi, S , Fransen, M , Heineman, D , Radonic, T, van de Ven, P, Meijboom, L , Oprea-Lager, D , Garcia-Vallejo, J, Bouwhuis, N, de Gruijl, TD & Bahce, I 2021, 'Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial', Annals of Oncology, vol. 32, pp. S1427-S1427. https://doi.org/10.1016/j.annonc.2021.10.137

TY - JOUR

T1 - Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial

AU - Dickhoff, C.

AU - Senan, S.

AU - Schneiders, F. L.

AU - Veltman, J.

AU - Hashemi, S.

AU - Fransen, M.

AU - Heineman, D.

AU - Radonic, T.

AU - van de Ven, P.

AU - Meijboom, L.

AU - Oprea-Lager, D.

AU - Garcia-Vallejo, J.

AU - Bouwhuis, N.

AU - de Gruijl, T. D.

AU - Bahce, I.

PY - 2021/12

Y1 - 2021/12

U2 - https://doi.org/10.1016/j.annonc.2021.10.137

DO - https://doi.org/10.1016/j.annonc.2021.10.137

M3 - Meeting Abstract

SN - 0923-7534

VL - 32

SP - S1427-S1427

JO - Annals of oncology

JF - Annals of oncology

ER -